Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.

Immune-Mediated Therapies for Liver Cancer. Genes (Basel) (2017) 0.75

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer (2011) 6.44

The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev (2002) 3.28

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol (2004) 1.87

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology (2012) 1.68

Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study. Cancer Biol Ther (2010) 1.55

Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol (2015) 1.54

Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma. Cancer Res (2014) 1.49

Strategies for immunotherapy of cancer. Adv Immunol (2000) 1.36

Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol (2015) 1.24

Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res (2014) 1.23

Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Semin Immunol (2009) 1.18

Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther (2008) 1.12

Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano (2014) 1.10

Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology (2001) 1.02

Immunotherapeutic approaches to hepatocellular carcinoma treatment. Liver Cancer (2012) 1.00

Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine. Clin Dev Immunol (2013) 1.00

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model. Hepatology (2012) 0.93

Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients. Photochem Photobiol Sci (2011) 0.93

Immunotherapy for liver tumors: present status and future prospects. J Biomed Sci (2009) 0.92

Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice. J Immunol (2006) 0.90

Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World J Hepatol (2014) 0.88

Glycated chitosan as a new non-toxic immunological stimulant. Immunopharmacol Immunotoxicol (2009) 0.87

Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma. J Clin Cell Immunol (2015) 0.84

Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era? Expert Rev Clin Immunol (2015) 0.83

Immunostimulatory properties of glycated chitosan. J Xray Sci Technol (2011) 0.83

InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Lett (2015) 0.82

Pembrolizumab superior to ipilimumab in melanoma. Cancer Discov (2015) 0.80

"Infectious" optimism for treatment of hepatocellular carcinoma. Mol Ther (2013) 0.80

Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol (2015) 0.79

Synergistic effect of photothermal and photoimmunological reactions in treatment of metastatic tumors. J Xray Sci Technol (2002) 0.78

Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer. Cancer Biol Ther (2015) 0.78

InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Lett (2015) 0.82